Skip to main content
. Author manuscript; available in PMC: 2019 Jun 19.
Published in final edited form as: Clin Cancer Res. 2019 Jan 22;25(8):2644–2655. doi: 10.1158/1078-0432.CCR-18-1401

Figure 4.

Figure 4.

Impact of PD-L1 expression on the association of HLA-A and β2m expression by PanNET cells and of TAM number with DSS in patients with PanNET. A and B, Prognosis is depicted with Kaplan-Meier curves for HLA-A expression (positive and heterogeneous vs. negative) in PD-L1-negative (P=0.02) and positive (P=0.057) group. C and D, Prognosis is depicted with Kaplan-Meier curves for β2m expression (positive and heterogeneous vs. negative) in PD-L1–negative (P=0.03) and positive (P=0.085) group. E and F, Prognosis is depicted with Kaplan-Meier curves for TAM number (high vs. medium and low) in PD-L1-negative (P=0.02) and positive (P=0.057) group. P values derived from logrank tests.